Comparison Between Immunohistochemistry and Modified Giemsa Staining for Identification of Helicobacter spp in Stomach Biopsy
DOI:
https://doi.org/10.36408/mhjcm.v10i3.959Keywords:
anti-Helicobacter pylori immunohistochemistry, Helicobacter spp, Helicobacter pylori identification, modified Giemsa, staining methodsAbstract
BACKGROUND: Helicobacter pylori is classified as a grade 1 carcinogen by the International Agency for Research on Cancer. Identification of Helicobacter pylori infection is crucial for the prevention of malignancy. Immunohistochemistry is more specific and sensitive than modified Giemsa because it based on the antigen- antibody binding so it can exclude other organisms. However, it can be expressed in all species of Helicobacter genus.
OBJECTIVE: To compare the identification methods of Helicobacter spp in stomach biopsy between modified Giemsa and immunohistochemistry.
METHOD: This research was a cross-sectional study. There were 64 biopsies taken by simple random sampling. They consisted of 32 positive and 32 negative Helicobacter spp based on the interpretation of modified Giemsa. Statistical analysis using x2 test.
RESULT: The number of atypical Helicobacter spp was 42.%. The number of samples that received Proton Pump Inhibitor (PPI) therapy was 93.75%. Helicobacter spp was positive in 31 samples and negative in 33 samples based on the interpretation of immunohistochemistry staining. There was no significant difference (p=0.617) between the identification results of Helicobacter spp using immunohistochemistry compared to the Modified Giemsa at both 400x and 1000x magnification.
CONCLUSION: Modified Giemsa is still reliable for identifying Helicobacter spp, especially in classical form, compared to immunohistochemistry. Due to the administration of PPI, there are a lot of cases with atypical form of Helicobacter spp which can be differentiated into coccoid form and intraepithelial located. Immunohistochemistry staining is useful in identify these cases.
Downloads
References
1. Tempera PJ, Michael M, Tageldin O, Hasak S. Gastric Cancer Due to Chronic H. pylori Infection: What We Know and Where We Are Diseases. 2022 Aug 25;10(3):57.
2. Bamanikar S, Khandelwal A, Shah K, Bamanikar A, Buch A. Detection of Helicobacter Pylori in Gastric Biopsies of Patients with Chronic Gastritis: Histopathological and Immunohistochemical Int J Health Sci Res [Internet]. 2018;8:39. Available from: www.ijhsr.org
3. Syam AF, Simadibrata M, Makmun D, Abdullah M, Fauzi A, Renaldi K, et al. National Consensus on Management of Dyspepsia and Helicobacter pylori Infection. Vol. 49, Acta Med Indones-Indones J Intern Med. 2017 p. 279–87.
4. Syam AF, Miftahussurur M, Makmun D, Nusi IA, Zain LH, Zulkhairi, et al. Risk factors and prevalence of Helicobacter pylori in five largest islands of Indonesia: A preliminary PLoS One. 2015;10(11):1–14.
5. Uchida T, Miftahussurur M, Pittayanon R, Vilaichone R, Wisedopas N, Ratanachu-Ek T, et al. Helicobacter pylori infection in Thailand: A nationwide study of the CagA PLoS One. 2015;10(9):1–13.
6. Glickman JN, Noffsinger A, Nevin DT, Ray M, Lash RH, Genta RM. Helicobacter infections with rare bacteria or minimal gastritis: Expecting the unexpected. Digestive and Liver 2015 Jul;47(7):549–55.
7. Kocsmár É, Szirtes I, Kramer Z, Szijártó A, Bene L, Buzás GM, et al. Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory Helicobacter. 2017;22(4):1–9.
8. Lash RH, Genta RM. Routine Anti-Helicobacter Immunohistochemical Staining is Significantly Superior to Reflex Staining Protocols for the Detection of Helicobacter in Gastric Biopsy Specimens. Helicobacter. 2016;21(6).
9. Sandhika W. Detection of Helicobacter Pylori Infection in Chronic Gastritis Biopsy Specimen Using Warthin-Starry and Modified Giemsa Stain in Dr Soetomo Hospital Indonesian Journal of Tropical and Infectious Disease. 2019;7(6):150.
10. Nurdin W, Krisnuhoni E, Kusmardi K. Comparison of Helicobacter pylori Detection Using Immunohistochemistry and Giemsa and Its Association with Morphological Changes in Active Chronic Gastritis. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive 2016;17(1):21.
11. Ginestet F, Guibourg B, Doucet L, Théreaux J, Robaszkiewicz M, Marcorelles P, et al. Upfront immunohistochemistry improves specificity of Helicobacter pylori diagnosis. A French pathology laboratory point of view. 2017 Oct;22(5):e12424.
12. Farouk WI, Hassan NH, Ismail TR, Daud IS, Mohammed F. Warthin-Starry staining for the detection of Helicobacter pylori in gastric biopsies. Malaysian Journal of Medical 2018;25(4):92–9.
13. Boldt MS, Pereira RD, Barbosa AJA. Histological identification of H. pylori stained by hematoxylin-eosin and Giemsa: Review for quality control. J Bras Patol Med Lab. 2015;51(2):108–12.
14. Fan CC, Chen CH, Chou C, Kao TY, Cheng AN, Lee AYL, et al. A time-saving–modified Giemsa stain is a better diagnostic method of Helicobacter pylori infection compared with the rapid urease J Clin Lab Anal. 2020;34(4):1–5.
15. Prabhu R K, Jayaraman A. Immunohistochemistry on Helicobacter pylori : An institutional diagnostic hands-on review. GJRA - Global Journal For Research Analysis. 2017;6(9):155–7.
16. Loharamtaweethong K, Puripat N. Comparison of immunohistochemistry and conventional stains for helicobacter pylori detection in gastric biopsies of patients receiving proton pump inhibitors. Journal of Health Science and Medical Research. 2020;38(4):321–30.
17. Aziz ZW, Saleem SH, Al-Nuaimy HA. Helicobacter pylori in Gastric biopsy: A Histochemical and Immunohistochemical Assessment. Annals of the College of Medicine, 2020;41(2):139–47.
18. Pittman ME, Khararjian A, Wood LD, Montgomery EA, Voltaggio L. Prospective identification of Helicobacter pylori in routine gastric biopsies without reflex ancillary stains is cost-efficient for our health care Hum Pathol [Internet]. 2016 Dec;58:90–Available from: https://linkinghub.elsevier.com/retrieve/pii/S0046817716301988
19. Decker L, Routh JK, Snider JS, Hanson JA. Selective staining of gastric biopsies for H. pylori does not affect detection rates or turnaround time and improves cost compared to reflexive Pathol Res Pract. 2017 Jan;213(1):23–6.
20. Riba AK, Ingeneri TJ, Strand CL. Improved Histologic Identification of Helicobacter pylori by Immunohistochemistry Using a New Novocastra Monoclonal Antibody. Lab 2011;42(1):35–9.
21. Miftahussurur M, Syam AF, Nusi IA, Makmun D, Waskito LA, Zein LH, et al. Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic PLoS One. 2016 Dec 1;11(12):e0166199.
22. Syam AF, Miftahussurur M, Makmun D, Abdullah M, Rani AA, Siregar GA, et Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report. Gut Pathog. 2023 May 22;15(1):25.
23. Wu W, Leja M, Tsukanov V, Basharat Z, Hua D, Hong W. Sex differences in the relationship among alcohol, smoking, and Helicobacter pylori infection in asymptomatic Journal of International Medical Research. 2020 May 28;48(5):030006052092603.
24. Xia Y, Meng G, Zhang Q, Liu L, Wu H, Shi H, et al. Dietary Patterns are Associated with Helicobacter Pylori Infection in Chinese Adults: A Cross-Sectional Study. Sci Rep. 2016 Aug 30;6(1):32334.
25. Alkhamiss AS. Evaluation of Better Staining Method among Hematoxylin and Eosin, Giemsa and Periodic Acid Schiff-Alcian Blue for the Detection of Helicobacter pylori in Gastric Malaysian Journal of Medical Sciences. 2020 Oct 27;27(5):53–61.
26. Chitkara Y. Upfront Special Staining for Helicobacter pylori in Gastric Biopsy Specimens Is Not Am J Clin Pathol. 2015 Jan 1;143(1):84–8.
27. Son JH, Lebwohl B, Sepulveda AR, Lagana SM. Utilization Rate of Helicobacter pylori Immunohistochemistry Is Not Associated with the Diagnostic Rate of Helicobacter pylori Applied Immunohistochemistry and Molecular Morphology. 2019;27(9):694–8.
28. Patnayak R, Reddy V, Reddy Mk, Rukmangadha N, Jena A, Parthasarathy S. Utility of immunohistochemistry in demonstrating Helicobacter pylori. Oncology, Gastroenterology and Hepatology Reports. 2015;4(1):4.
29. Charitos IA, D’Agostino D, Topi S, Bottalico L. 40 years of Helicobacter pylori: A revolution in biomedical thought. Gastroenterol 2021;12(2):111–35.
30. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility Clin Microbiol Rev. 2007;20(2):280–322.
31. Morris GB, Ridgway EJ, Suvarna SK. Traditional stains and modern techniques for demonstrating microorganisms in histology. In: Suvarna SK, Layton C, Bancroft JD, Bancroft’s Theory and Practice of Histological Techniques. 8th ed. Sheffield, United Kingdom: Elsevier; 2019. p. 254–77.
32. Buharideen SM, Wijetunge S, Jayamaha T, Sinnadurei A, Waduge R, Ratnatunga CN. Evaluation of histology as a Helicobacter pylori detection method and analysis of associated Journal of Diagnostic Pathology. 2016;10(2):5.
33. Lee JY, Kim Diagnosis of Helicobacter pylori by invasive test: Histology. Ann Transl Med. 2015;3(1):1–8.
34. Kocak C, Kucuk S, Ercihan E, Gundogan M, Sakar C, Uncu A, et al. Does anti- Helicobacter pylori immunohistochemical staining has a confirmative role in the definitive diagnosis of negative gastric biopsy samples stained with routine histological stains? Medicine Science | International Medical 2019;8(4):786.
35. Akeel M, Elhafey A, Shehata A, Elmakki E, Aboshouk T, Ageely H, et al. Efficacy of immunohistochemical staining in detecting Helicobacter pylori in Saudi patients with minimal and atypical European Journal of Histochemistry. 2021 Jul 20;65(3).
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2023 Fenny Halim, Devia Eka Listiana, Vega Karlowee, Hermawan Istiadi, Awal Prasetyo, Meira Dewi Kusuma Astuti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
